Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (459)
  2. Journal Article (316)
  3. Review (21)
  4. Guidelines (12)
  5. Research Letter (12)
  6. Book Section (8)
  7. Correspondence (5)
  8. Editorial (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (840)
  2. Center for Hematologic Malignancies (840)
  3. Department of Medicine (840)
  4. Hematologic Malignancies, Division of (840)
  5. Survivorship Research (422)
  6. CTCR Scholars (362)

More Groups

People
  1. Sergio Giralt (407)
  2. Sean Devlin (272)
  3. Ann Jakubowski (238)
  4. Esperanza Papadopoulos (228)
  5. Craig Sauter (194)
  6. Molly Maloy (194)

More People

Years
  1. 2024 (9)
  2. 2023 (101)
  3. 2022 (95)
  4. 2021 (67)
  5. 2020 (93)
  6. 2019 (81)

More Years

Publications
  1. Blood (237)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (77)
  4. Transplantation and Cellular Therapy (58)
  5. Blood Advances (36)
  6. Journal of Clinical Oncology (26)

More Publications

Publishers
  1. Elsevier Inc. (289)
  2. American Society of Hematology (274)
  3. Nature Publishing Group (97)
  4. American Society of Clinical Oncology (26)
  5. Oxford University Press (16)
  6. Wiley Blackwell (14)

More Publishers

Results (840)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Estimating the lifetime medical cost burden of an allogeneic hematopoietic cell transplantation patient
    Journal Article

    Maziarz, R. T.; Devine, S.; Garrison, L. P.; Agodoa, I.; Badaracco, J.; Gitlin, M.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Updated indications for immune effector cell therapy: 2023 guidelines from the American Society for Transplantation and Cellular Therapy
    Guidelines

    Kanate, A. S.; Majhail, N.; DeFilipp, Z.; Dhakal, B.; Dholaria, B.; Hamilton, B.; Herrera, A. F.; Inamoto, Y.; Jain, T.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Emergence of human CMV-induced NKG2C(+) NK cells is associated with CD8(+) T-cell recovery after allogeneic HCT
    Journal Article

    van der Ploeg, K.; Sottile, R.; Kontopoulos, T.; Shaffer, B. C.; Papanicolaou, G. A.; Maloy, M. A.; Cho, C.; Robinson, K. S.; Perales, M. A.; Jean-Benoît, L. L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma
    Journal Article

    Scordo, M.; Flynn, J. R.; Gonen, M.; Devlin, S. M.; Parascondola, A.; Tomas, A. A.; Shouval, R.; Brower, J.; Porter, D. L.; Schuster, S. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
    Journal Article

    Fingrut, W. B.; Gyurkocza, B.; Flynn, J.; Davis, E.; Devlin, S.; Scaradavou, A.; Chinapen, S.; Quach, S.; Cho, C.; Giralt, S. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • ASTCT clinical practice recommendations for transplantation and cellular therapies in diffuse large B cell lymphoma
    Guidelines

    Epperla, N.; Kumar, A.; Abutalib, S. A.; Awan, F. T.; Chen, Y. B.; Gopal, A. K.; Holter-Chakrabarty, J.; Kekre, N.; Lee, C. J.; Lekakis, L.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
    Journal Article

    Bhaskar, S. T.; Patel, V. G.; Porter, D. L.; Schuster, S. J.; Nastoupil, L. J.; Perales, M. A.; Tomas, A. A.; Bishop, M. R.; McGuirk, J. P.; Maziarz, R. T.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Phase 1 results with anti-CD19 allogeneic CAR T ALLO-501/501A in relapsed/refractory large B-cell lymphoma (r/r LBCL)
    Meeting Abstract

    Locke, F. L.; Lekakis, L. J.; Eradat, H.; Munoz, J.; Tees, M. T.; de Vos, S.; Nath, R.; Stevens, D. A.; Malik, S.; Popplewell, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Primary overall survival analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel versus standard-of-care therapy in relapsed/refractory large B-cell lymphoma
    Meeting Abstract

    Westin, J.; Oluwole, O. O.; Kersten, M. J.; Miklos, D. B.; Perales, M. A.; Ghobadi, A.; Rapoport, A.; Sureda, A.; Jacobson, C. A.; Farooq, U.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save